Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted to explore the safety and tolerability and plasma pharmacokinetics of
NRL001 after single intra-anal dose of 1mL cream at increasing concentrations.